Occitanie Innovation Biotherapy is a partner of the 12th Antibody Industrial Symposium (AIS2024).

The 12th AIS2024 jointly organized by the scientific society LabEx MAbImprove and MabDesign, the French association of the Biotherapy Industrial sector, will be held on June 20-21 2024, in Montpellier, France.

The AIS2024 is the ideal conference for scientists, industrials, clinicians, and policy makers to exchange about therapeutic antibodies and more! This year’s 2-days-programme is organized into several tracks covering the hot topics in antibody, recombinant proteins, CART cells and other biopharmaceuticals research and development. Moreover, the program will allow opportunities for one-to-one meetings, companies to showcase their new products and technologies virtually as well as dedicated time for business partnering.

Submit your Abstract to give a Pitch presentation or present your Poster at the AIS2024. Abstract submission deadline is April 12th, 2024! Check guideline HERE

mAbs, bi- multi-specifics, Immunotherapy, developability, Ab-like molecules, immunocytokines, adoptive cell therapy, CAR-T cells, drug discovery, ADCs, analytics, patient stratification, PK/PD, AI & Machine Learning, bioprocessing

More information about AIS 2024

https://aiscongress.com/

Contact

Ana Sofia Antunes – Head of International Affairs, Scientific Events & Communication ana-sofia.antunes@mabdesign.fr I Tel. +33 (0)6 26 33 63 21